ISRG VP Corporate Controller Fredrik Widman Sells $1.8M of Stock

On October 23, 2026, Fredrik Widman, the VP Corporate Controller at Intuitive Surgical, Inc. (ISRG), sold 4,047 shares for approximately $1.83 million. This transaction was made at an average price of $453.21 per share, while the stock closed at $452.29 that same day according to his Form 4 filing with the SEC.

Widman's sale significantly reduced his holdings in the company, cutting his stake by about 79.78%. After this transaction, he now owns just 1,026 shares of Intuitive Surgical.

ISRG Intuitive Surgical, Inc.

$452.29 ▼ -19.52% year to date

1M 3M YTD

Daily close · Oct 23, 2026

Other Institutional Activity in Intuitive Surgical

Foster Victor Wealth Advisors increased its stake in Intuitive Surgical by 2,915 shares, bringing its total to 22,749 shares worth about $9.85 million. This reflects a 14.7% rise in their holdings.

Intuitive Surgical, Inc. Stock Up 1.8%

Intuitive Surgical recently traded around $451.64, which is about equal to its closing price of $452.29 on October 23. The stock is currently above its 50-day moving average by about 14% and its 200-day moving average by approximately 3.5%. However, it is about 25.2% below its 52-week high of $603.88.

Recent Earnings

Intuitive Surgical reported trailing twelve-month revenue of about $11.58 billion, with a year-over-year revenue growth of 21.7%. The next earnings report is expected on January 21, 2027.

Insider Buying and Selling at Intuitive Surgical, Inc.

In addition to Widman's sale, other insiders also sold shares on the same day. Gary S Guthart, a Director, sold 20,095 shares for about $9.1 million, while Patricia L Wadors, the SVP Chief Human Resources Officer, sold 1,078 shares for around $478,416.40. These transactions show a trend of selling among key executives.

Analysts Set New Price Targets

On October 21, 2026, several firms maintained their ratings on Intuitive Surgical. Leerink Partners kept its "Outperform" rating with a price target of $503, while JP Morgan maintained an "Overweight" rating with a target of $475. Overall, the consensus recommendation remains a "buy" with a mean price target of $478.30.

About Intuitive Surgical

Intuitive Surgical, Inc. develops and sells robotic surgical systems and instruments that help healthcare providers perform minimally invasive surgeries. Its innovative products aim to enhance the quality of care for patients worldwide.

Bottom Line

Investors should keep an eye on Intuitive Surgical's upcoming earnings report on January 21, 2027, for more insights into the company's performance. Additionally, with recent insider sales, it may be worth monitoring any further changes in insider activity.